Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR

Progenics' (PGNX) Relistor Setback Only a Speedbump - Jefferies

April 5, 2016 9:34 AM EDT

Jefferies analyst, Gena Wang, sees the FDA extension for Progenics Pharmaceuticals' (NASDAQ: PGNX) oral Relistor as a timing setback only. No change to Buy rating or $9 PT.

The FDA extended the PDUFA by 3mon (to July 19) for oral Relistor in opioidinduced constipation in... More

Needham & Company Defends Progenics (PGNX) on PDUFA Delay, Valeant Overhang

April 4, 2016 1:23 PM EDT

Needham & Company analyst Chad Messer has come out to defend Progenics Pharmaceuticals (NASDAQ: PGNX), which is down 6.5% after the FDA extended oral Relistor PDFUA by 3 months to July 19th. The FDA made the extension in order to review responses by Valeant to recent... More